BAKER IDI HEART AND DIABETES INSTITUTE HOLDINGS LTD
发明人:
KAYE, DAVID MARTIN,KRIPPNER, GUY,MARIAPPAN, GEETHA THANGA
申请号：
EP12824391
公开号：
EP2744496A4
申请日:
2012.08.16
申请国别(地区):
EP
年份:
2015
代理人:
摘要：
The present invention relates to oral controlled-release formulations of 5-(pyridinyl)-2(1H)-pyridinone compounds and their use in the treatment of a subject with heart failure, a stage, class or manifestation of heart failure, or at risk of developing or exhibiting symptoms of heart failure. The formulations of the invention release the compounds in the range of between 0.1 &mug/kg body weight/minute and 20 &mug/kg body weight/minute.
